News
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 ...
Atha Energy Corp., a mineral company, engages in the acquisition, exploration, and evaluation of mineral resources in Canada. It explores for uranium deposits. The company was formerly known as ...
ATHA holds the largest reported cumulative exploration package in the Athabasca Basin – the world’s most prominent basin for uranium discoveries. Exploration Acreage in “Great ...
ATHA ENERGY SHARES TO COMMENCE TRADING ON THE CSE UNDER THE SYMBOL "SASK" ON TUESDAY, APRIL 11, 2023
ATHA holds the largest reported cumulative exploration package in the Athabasca Basin – the world's most prominent basin for uranium discoveries. Provided Content: Content provided by Newswire ...
VANCOUVER, British Columbia and TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSXV: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) and Latitude Uranium ...
VANCOUVER, BC / ACCESS Newswire / May 14, 2025 / ATHA Energy Corp. (TSXV:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" or the "Company"), holder of the largest uranium exploration portfolio in two of the ...
The latest analyst rating for Athira Pharma (NASDAQ:ATHA) was provided by Mizuho, and Athira Pharma downgraded their neutral rating. The last downgrade for Athira Pharma Inc happened on September ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results